Golde Named Physician-in Chief at Memorial Hospital

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 23 No 5
Volume 23
Issue 5

NEW YORK--Dr. David W. Golde has been appointed Physician-in-Chief of Memorial Hospital, Dr. Paul Marks, president of Memorial Sloan-Kettering Cancer Center, announced. Dr. Golde succeeds Joseph V. Simone, MD, who is to become clinical director for the Huntsman Cancer Institute, Salt Lake City.

NEW YORK--Dr. David W. Golde has been appointed Physician-in-Chiefof Memorial Hospital, Dr. Paul Marks, president of Memorial Sloan-KetteringCancer Center, announced. Dr. Golde succeeds Joseph V. Simone,MD, who is to become clinical director for the Huntsman CancerInstitute, Salt Lake City.

Dr. Golde was head of the Cancer Center's Division of HematologicOncology, Department of Medicine, as well as head of the Laboratoryof Molecular and Cellular Hematology at the Sloan-Kettering Institute.He is renowned for his contributions to the understanding of normaland leukemic blood cell growth. His demonstration that certainwhite blood cells produce colony-stimulating factors in humanslaid the groundwork for the isolation of these factors.

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content